Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MST-188 in Acute Lower Limb Ischemia
NCT02093468Phase 2Terminated
- Sponsor
- Mast Therapeutics, Inc.
- Start
- Jun 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vepoloxamer in acute limb ischemia (ALI), sponsored by Mast Therapeutics, Inc.. Started Jun 2014; status: terminated.
02
Drugs
vepoloxamer
03
Conditions
acute limb ischemia (ALI)
Beyond the preview
Go deeper on NCT02093468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02093468.